{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:54:55Z","timestamp":1740135295947,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Development Program of Children's Hospital of Fudan University","award":["EK2022ZX01","EK2022ZX06"],"award-info":[{"award-number":["EK2022ZX01","EK2022ZX06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal Muscular Atrophy (SMA) is a severe neuromuscular disorder due to a defect in the survival motor neuron 1 (<jats:italic>SMN1<\/jats:italic>) gene. Hypoplasia of the corpus callosum is underdevelopment or thinness of the corpus callosum. SMA and callosal hypoplasia are relatively rare, and there is limited information sharing the diagnosis and treatment for SMA patients with callosal hypoplasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case description<\/jats:title>\n                <jats:p>A boy with callosal hypoplasia, small penis, and small testes had been perceived with motor regression at 5\u00a0months. He was referred to the rehabilitation department and neurology department at 7\u00a0months. Physical examination showed absent deep tendon reflexes, proximal weakness and significant hypotonia. He was recommended to perform trio whole-exome sequencing (WES) and array comparative genomic hybridization (aCGH) for his complicated conditions. The subsequent nerve conduction study revealed some characteristics of motor neuron diseases. We identified a homozygous deletion in exon 7 of the <jats:italic>SMN1<\/jats:italic> gene by multiplex ligation-dependent probe amplification and failed to find further pathogenic variations responsible for multiple malformations by trio WES and aCGH. He was diagnosed as SMA. Despite some concerns, he received the therapy of nusinersen for nearly 2\u00a0years. He gained the milestone of sitting without support, which he had never accomplished, after the seventh injection, and he continued to improve. During follow-up, there were no adverse events reported and no signs of hydrocephalus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Some extra features which could not belong to neuromuscular manifestation made the diagnosis and treatment of SMA more complicated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03121-w","type":"journal-article","created":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T06:10:46Z","timestamp":1676700646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spinal muscular atrophy with hypoplasia of the corpus callosum: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaomei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-2557","authenticated-orcid":false,"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"3121_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell"},{"key":"3121_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1096-8628(19971003)72:1<51::AID-AJMG11>3.0.CO;2-T","volume":"72","author":"LR Simard","year":"1997","unstructured":"Simard LR, Rochette C, Semionov A, Morgan K, Vanasse M. SMN(T) and NAIP mutations in Canadian families with spinal muscular atrophy (SMA): genotype\/phenotype correlations with disease severity. Am J Med Genet. 1997;72:51\u20138.","journal-title":"Am J Med Genet"},{"key":"3121_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/hmg\/4.4.631","volume":"4","author":"NR Rodrigues","year":"1995","unstructured":"Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet. 1995;4:631\u20134.","journal-title":"Hum Mol Genet"},{"key":"3121_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/hmg\/5.2.257","volume":"5","author":"E Velasco","year":"1996","unstructured":"Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet. 1996;5:257\u201363.","journal-title":"Hum Mol Genet"},{"key":"3121_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15:228\u201337.","journal-title":"Hum Mutat"},{"issue":"21","key":"3121_CR6","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/ijms21093297","volume":"7","author":"TH Chen","year":"2020","unstructured":"Chen TH. New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand? Int J Mol Sci. 2020;7(21):3297.","journal-title":"Int J Mol Sci"},{"key":"3121_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrn2107","volume":"8","author":"LK Paul","year":"2007","unstructured":"Paul LK, Brown WS, Adolphs R, Tyszka JM, Richards LJ, Mukherjee P, et al. Agenesis of the corpus callosum: Genetic, developmental and functional aspects of connectivity. Nat Rev Neurosci. 2007;8:287\u201399.","journal-title":"Nat Rev Neurosci"},{"key":"3121_CR8","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/ajmg.a.32418","volume":"146A","author":"HC Glass","year":"2008","unstructured":"Glass HC, Shaw GM, Ma C, Sherr EH. Agenesis of the corpus callosum in California 1983\u20132003: A population-based study. Am J Med Genet [A]. 2008;146A:2495\u2013500.","journal-title":"Am J Med Genet [A]"},{"key":"3121_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2011.01.002","volume":"44","author":"N Szab\u00f3","year":"2011","unstructured":"Szab\u00f3 N, Gergev G, K\u00f3bor J, Bereg E, T\u00fari S, Sztriha L. Corpus callosum anomalies: birth prevalence and clinical spectrum in Hungary. Pediatr Neurol. 2011;44:420\u20136.","journal-title":"Pediatr Neurol"},{"key":"3121_CR10","first-page":"7","volume":"58","author":"WB Dobyns","year":"1996","unstructured":"Dobyns WB. Absence makes the search grow longer. Am J Hum Genet. 1996;58:7\u201316.","journal-title":"Am J Hum Genet"},{"key":"3121_CR11","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/ajmg.a.32476","volume":"146A","author":"CC Schell-Apacik","year":"2008","unstructured":"Schell-Apacik CC, Wagner K, Bihler M, Ertl-Wagner B, Heinrich U, Klopocki E, et al. Agenesis and dysgenesis of the corpus callosum: Clinical, genetic and neuroimaging findings in a series of 41 patients. Am J Med Genet A. 2008;146A:2501\u201311.","journal-title":"Am J Med Genet A"},{"key":"3121_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723\u201332.","journal-title":"N Engl J Med"},{"key":"3121_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-020-01356-1","volume":"15","author":"E Mercuri","year":"2020","unstructured":"Mercuri E, Lucibello S, Perulli M, Coratti G, de Sanctis R, Pera MC, et al. Longitudinal natural history of type I spinal muscular atrophy: a critical review. Orphanet J Rare Dis. 2020;15:84.","journal-title":"Orphanet J Rare Dis"},{"key":"3121_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.25549","volume":"86","author":"RH Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a RH, Rocha AJ, Lozano-Arango A, Diaz AB, Castiglioni C, Silva AMS, et al. Severe brain involvement in 5q spinal muscular atrophy type 0. Ann Neurol. 2019;86:458\u201362.","journal-title":"Ann Neurol"},{"key":"3121_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s13760-020-01524-x","volume":"121","author":"L Losito","year":"2021","unstructured":"Losito L, Gennaro L, Lucarelli E, Trabacca A. Brain MRI abnormalities in a child with spinal muscular atrophy type II. Acta Neurol Belg. 2021;121:1883\u20135.","journal-title":"Acta Neurol Belg"},{"key":"3121_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","volume":"109","author":"CJJ Yeo","year":"2020","unstructured":"Yeo CJJ, Darras BT. Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease. Pediatr Neurol. 2020;109:12\u20139.","journal-title":"Pediatr Neurol"},{"key":"3121_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378:625\u201335.","journal-title":"N Engl J Med"},{"key":"3121_CR18","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1212\/WNL.0000000000007527","volume":"92","author":"BT Darras","year":"2019","unstructured":"Darras BT, Chiriboga CA, Iannaccone ST, Swoboda KJ, Montes J, Mignon L, et al. Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1\/2 studies. Neurology. 2019;92:e2492\u2013506.","journal-title":"Neurology"},{"key":"3121_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mus.27187","volume":"63","author":"G Acsadi","year":"2021","unstructured":"Acsadi G, Crawford TO, M\u00fcller-Felber W, Shieh PB, Richardson R, Natarajan N, et al. Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study. Muscle Nerve. 2021;63:668\u201377.","journal-title":"Muscle Nerve"},{"key":"3121_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1212\/WNL.0000000000006502","volume":"91","author":"D Michelson","year":"2018","unstructured":"Michelson D, Ciafaloni E, Ashwal S, Lewis E, Narayanaswami P, Oskoui M, et al. Evidence in focus: nusinersen use in spinal muscular atrophy. Neurology. 2018;91:923\u201333.","journal-title":"Neurology"},{"key":"3121_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day JW, Finkel RS, Chiriboga CA, Connolly AM, Crawford TO, Darras BT, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021;20:284\u201393.","journal-title":"Lancet Neurol"},{"key":"3121_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13023-021-01822-4","volume":"16","author":"E Viscidi","year":"2021","unstructured":"Viscidi E, Wang N, Juneja M, Bhan I, Prada C, James D, et al. The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study. Orphanet J Rare Dis. 2021;16:207.","journal-title":"Orphanet J Rare Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03121-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T06:10:54Z","timestamp":1676700654000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03121-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3121"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03121-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this case was not involved in any experimental interventions, no formal research ethics approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The relatives of this patient provided written informed consent to the publication of the information and images related to this manuscript. This report does not contain any personal information that could lead to the identification of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare that they have no conflict of interests and that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}